What conditions could cause a 54-year-old female to have multiple sites of bursitis, degenerative disc disease, and several ankle tendon tears?

Systemic Inflammatory Arthropathy, Most Likely Axial Spondyloarthritis or Rheumatoid Arthritis

This constellation of multiple bursitis sites, degenerative disc disease, and ankle tendon tears in a 54-year-old woman strongly suggests an underlying systemic inflammatory rheumatic disease, particularly axial spondyloarthritis (axSpA) or rheumatoid arthritis (RA), rather than isolated mechanical/degenerative pathology.

Primary Differential Diagnosis

Axial Spondyloarthritis (Most Likely)

The combination of spinal degenerative changes with multiple sites of bursitis and entheseal pathology (tendon tears at the ankle) is characteristic of axSpA 1. Key features include:

• Enthesitis (inflammation at tendon/ligament insertions) is a hallmark of axSpA and commonly affects the Achilles tendon insertion and plantar fascia 2
• Spine involvement with inflammatory changes that can mimic or coexist with degenerative disc disease 1
• Multiple sites of inflammation including sacroiliac joints, peripheral joints, and entheses 2

Critical diagnostic consideration: MRI findings of degenerative disc disease should be interpreted cautiously, as both inflammatory and fatty lesions in axSpA can be mistaken for degenerative changes 1. The presence of disc degeneration or osteophytes may favor degenerative pathology, but inflammatory spondylitis can coexist.

Rheumatoid Arthritis (Second Most Likely)

RA commonly presents with multiple sites of bursitis and tendon involvement 3, 4:

• Retrocalcaneal bursitis precedes or accompanies Achilles tendon enthesitis in early RA, with entheseal inflammation arising from synovial tissues 3
• Multiple bursitis sites including intermetatarsal, olecranon, and other locations are well-documented in RA 4
• Tendon tears occur from chronic inflammatory tenosynovitis

Recommended Diagnostic Workup

Imaging Priority

1. MRI of sacroiliac joints AND spine - This is the gold standard for axSpA diagnosis 1

   • Look for active inflammatory changes (spondylitis, spondylodiscitis)
   • Identify fatty corner lesions (≥3 sites suggests axSpA with 98% specificity) 1
   • Evaluate for syndesmophytes, erosions, and ankylosis

2. Ankle MRI - Already likely obtained given tendon tear diagnosis

   • Assess for retrocalcaneal bursitis and Achilles enthesitis pattern 3
   • Evaluate synovial proliferation

Laboratory Testing

• Inflammatory markers: ESR, CRP (elevated in active inflammatory disease)
• HLA-B27 (positive in 80-90% of axSpA cases)
• Rheumatoid factor and anti-CCP antibodies (for RA)
• ANA panel (to exclude other connective tissue diseases)

Clinical Features to Elicit

• Inflammatory back pain pattern: Morning stiffness >30 minutes, improvement with activity, nighttime awakening
• Peripheral joint involvement: Asymmetric oligoarthritis (axSpA) vs symmetric polyarthritis (RA)
• Extra-articular manifestations: Uveitis, psoriasis, inflammatory bowel disease (suggest spondyloarthritis)
• Disease duration: Early RA shows RCB preceding ATE, while established RA shows isolated ATE 3

Less Common But Important Considerations

Whipple's Disease

Chronic bursitis and tenosynovitis at multiple sites can be the presenting manifestation 5. Consider if:

• Gastrointestinal symptoms present
• Refractory to standard immunosuppression
• PCR testing for Tropheryma whipplei on bursal fluid

Mechanical/Degenerative Overlap

While pure mechanical causes are possible, the multiple simultaneous sites make systemic disease far more likely 6, 7:

• Isolated Baastrup disease (interspinous bursitis) occurs in only 8.2% of symptomatic patients and associates with age and canal stenosis 7
• Mechanical subacromial bursitis shows fibrosis, not the inflammatory infiltrate seen systemically 6

Critical Pitfalls to Avoid

1. Do not dismiss spine findings as "just degenerative" - Inflammatory and degenerative changes coexist and can be confused on imaging 1

2. Do not treat sites individually - Multiple simultaneous inflammatory sites demand systemic disease evaluation, not isolated corticosteroid injections 2

3. Do not delay rheumatology referral - Early diagnosis and treatment with DMARDs or biologics prevents structural damage and improves outcomes

4. Beware of tendon rupture risk - Local corticosteroid injections near tendons carry rupture risk, especially with underlying inflammatory tendinopathy 2

Immediate Management Approach

Refer urgently to rheumatology for definitive diagnosis and treatment initiation. While awaiting consultation:

• NSAIDs are first-line for symptom control in both axSpA and RA 2
• Avoid systemic corticosteroids for axial disease (not evidence-based) 2
• Consider selective corticosteroid injections only for severely symptomatic individual sites, avoiding areas near compromised tendons 2

The shared pathology across conditions involves IL-6, IL-1β, TNF-α, and macrophage infiltration 6, explaining why biologic therapies targeting these pathways are effective once diagnosis is established.